Home Monitoring for the Management of Age-Related Macular Degeneration: A Review of the Development and Implementation of Digital Health Solutions over a 25-Year Scientific Journey.

Miguel A Busquets¹, Richard A Garfinkel², Deepak Sambhara³, Nishant Mohan⁴, Kester Nahen⁴, Gidi Benyamini⁴, Anat Loewenstein⁵

¹Retina Associates of Kentucky, Lexington, KY 40509, USA.

²Retina Group of Washington, Chevy Chase, MD 20815, USA.

³Eye Clinic of Wisconsin, Wausau, WI 54403, USA.

⁴Notal Vision Inc., Manassas, VA 20109, USA.

⁵Tel Aviv Medical Center, Tel Aviv 6423906, Israel.

PubMed PMC DOI PDF

Abstract

The management of age-related macular degeneration (AMD) presents a significant challenge attributable to high disease heterogeneity. Patient realization of symptoms is poor and it is urgent to treat before permanent anatomic damage results in vision loss. This is true for the initial conversion from non-exudative intermediate AMD (iAMD) to exudative AMD (nAMD), and for the recurrence of nAMD unde…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.